iProgen Biotech Inc.
$600,000.00 CAD
≈ 8 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2019-2020
- Agreement period
- November 1, 2019 – December 31, 2021
- Reference
- nrc-cnrc:172-2019-2020-Q3-939055
Published purpose
CIIP Korea project NextGenADC will integrate the protein engineering expertise and enhanced antibody delivery technology of iProgen Biotech Inc. (Canada) with the unique linker-payload and site-specific conjugation technologies of AbTis Co., Ltd. (Korea). Together, this international partnership aims to create a next generation antibody-drug conjugate (ADC) as a potential therapeutic agent with a superior efficacy and safety profile for treating patients with solid tumours.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions